May 24th 2021
The UPcare Group based in Melbourne Australia have developed a natural plant based compound that has been proven in clinical trials to fight Covid19.
The UPCare Group are a leader in the discovery of antiviral therapies combating respiratory infections. It was founded by a group of leading scientists and researchers to address the growing concerns and proliferation of viruses and other transmitted illnesses through the human respiratory functions.
The scientific team from the UPcare Group has met with the White House Covid Task Force and WHO ( World Health Organisation) to discuss their scientific breakthrough in the fight against Covid 19.
The team presented conclusive results from clinical trials which proves that their natural plant based compounds successfully fights Sars-COV2 these trials were conducted under contract by Australia’s world renowned Doherty Institute.
The UPcare team of professors and scientists also presented other promising supporting data for all three of UPcare’s compounds. The Covid task force meeting was held with a view to UPcare’s products being used in hospitals & medical centres across the US to treat & fight Covid 19 in infected patients. The UPcare Group have also recently offered to donate some of their products to the Indian embassy in Australia to help Covid 19 patients in Indian hospitals.
The UPcare Group have successfully identified that one of their natural compounds, UP-A can successfully inhibit SARS-COV2 infection in Vero cells. A preliminary screen conducted under contract by the Doherty Institute, showed low micromolar inhibition of SARS-CoV2 by UP-A and similar levels of inhibition when combined with UPcare’s other compounds UP-U and UP-P.
The 3 natural compounds namely UP-A, UP-U, and UP-P are botanical extracts that have been used in medicinal formulations for centuries. They are derived from loquat, knotweed and chiretta.
The extracts used in each compound contain no hormones or residues. All of the critical ingredients have undergone long term studies and have passed assessments for subchronic and developmental toxicity, with no adverse reaction or side effects reported in humans.
Two of the natural compounds U and P are present in UPcare Groups product UPlus KBD Spray which is currently being sold over the counter and online as a TGA and FDA approved respiratory health and immune boosting product.
The UPcare Group which is currently privately funded are now in the process of raising a further $50 million AUD to continue the human trials required to prove that their TGA approved products UPlus A Spray and UPlus A Capsules containing all 3 compounds can also eliminate SARS-COV2 in infected individuals.
When UPcare Group’s human trials are complete it will be approved as a natural formulation available on the global market in the fight against SARS-COV2.
Both products can be purchased online and shipped overseas at https://upcare.tech/shop/
For more information contact [email protected]